← Every applicant
Amphastar Pharms Inc FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TERIPARATIDENew drugDec 12, 2025SOLUTION, SUBCUTANEOUS |
| REXTOVYNew drugMar 7, 2023SPRAY, METERED, NASAL |
| VASOPRESSINNew drugJul 18, 2022SOLUTION, INTRAVENOUS |
| GANIRELIX ACETATENew drugApr 7, 2022INJECTABLE, INJECTION |